Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy can contribute to dehydration, though it doesn't cause it directly. The risk comes mainly from side effects: nausea, vomiting and diarrhoea can lead to significant fluid loss, especially in the first weeks of treatment or after a dose increase. Semaglutide also slows gastric emptying, which affects how quickly fluids move through your system. Understanding when dehydration is a real concern (and when it isn't) helps you make sensible decisions while on treatment. Wegovy is a prescription-only medicine; a clinical assessment with a qualified prescriber is the right starting point before beginning or adjusting it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people asking whether semaglutide dehydrates them are weighing up how worried to be about the nausea they're already feeling, or deciding whether their symptoms need medical input. That's the right frame to use. Dehydration on Wegovy is rarely a direct drug effect; the medicine itself doesn't strip your body of water. What it does do is cause gastrointestinal side effects (nausea, vomiting, diarrhoea, and sometimes a general loss of appetite) that collectively reduce both your food and fluid intake. When those side effects are mild and brief, most people replace what they lose without thinking about it. When they're persistent or severe, the fluid deficit adds up faster than you might expect.
There's a second, subtler mechanism too. Appetite and thirst are closely linked physiologically. Many people on Wegovy notice they forget to drink as much as they used to, simply because the usual hunger cues that prompt snacking (and incidentally, a glass of something) have quietened. Keeping a water bottle visible during the day is a genuinely useful habit, not a cliché. Some patients tell our prescribers they keep one next to the kettle every morning so the first thing they do after taking their daily tablet is drink a full glass of water.
The NHS page on semaglutide for weight management lists gastrointestinal effects among the most commonly reported side effects, noting they tend to be most pronounced at the start of treatment or after a dose step-up. That timing pattern is important for calibrating your response. You can read more about what to expect across the Wegovy treatment overview page.
Mild thirst, a slightly reduced urge to drink, or one or two episodes of nausea are in a different category from sustained vomiting or diarrhoea. Signs that fluid loss is becoming clinically significant include a persistently dry mouth, dark or strongly smelling urine, dizziness on standing, a headache that doesn't resolve, and noticeably reduced urination over several hours. If you're vomiting repeatedly and can't keep fluids down, those symptoms warrant a call to your GP or NHS 111, not because Wegovy is dangerous, but because any condition that prevents fluid replacement needs prompt assessment.
The concern about kidneys is real and worth naming plainly. Prolonged dehydration can strain kidney function, and this is one reason the NHS advises people on GLP-1 medicines to seek medical help for severe or ongoing gastrointestinal illness rather than waiting it out. If you've been wondering whether Wegovy can lead to dehydration in your specific situation, the answer depends heavily on how severe your GI side effects have been and how consistently you've been replacing fluids. There's no single threshold; the clinical picture matters.
Eating a little (even small amounts of plain food) alongside regular sips of fluid tends to help settle nausea more effectively than restricting intake entirely. Some people find that spreading small meals evenly through the day reduces the wave-like nausea that an empty stomach can make worse. If you've eaten more than felt comfortable on Wegovy, that can also intensify GI symptoms temporarily, which feeds the dehydration risk.
The core strategy is straightforward: build fluid intake into your existing routine rather than trying to track it abstractly. Water is the priority; caffeinated drinks count toward total fluid but can mildly increase urine output, so they're less efficient. Oral rehydration salts (available from pharmacies without a prescription) can be useful if you've had a bout of vomiting or diarrhoea and want to replace electrolytes as well as water, they're not reserved for acute illness.
If nausea is the obstacle to drinking, try small, frequent sips rather than full glasses, especially in the morning. Cold or room-temperature fluids are better tolerated than hot drinks by many people experiencing nausea. Eating slowly and stopping well before feeling full reduces the chance of vomiting, which in turn preserves your fluid balance. The rate of weight loss on Wegovy is influenced partly by how consistently people can tolerate treatment, and managing fluid intake well enough to avoid hospitalisation or treatment interruption is a meaningful part of that. For practical guidance on how semaglutide works and what the evidence shows, the main semaglutide overview covers the mechanisms in detail.
If you're managing side effects and want to understand the broader picture of support available, the weight-loss treatment overview explains how clinical aftercare sits alongside the prescription itself. For context on how the costs and services compare across providers, the where to buy Wegovy page addresses the supply and pricing landscape.
Wegovy carries a Yellow Card reporting route for anyone who experiences side effects they consider serious or unexpected. The MHRA's Yellow Card scheme exists precisely because medicines with Black Triangle status (which includes Wegovy) are subject to additional post-market surveillance, and patient reports contribute to the evidence base. You don't need to be certain that the medicine caused the symptom; suspicion is enough to report.
Tell your prescriber urgently if you experience severe, persistent stomach pain that spreads to your back, with or without vomiting. This combination can occasionally indicate pancreatitis, which is a known but uncommon risk with GLP-1 medicines and requires prompt medical evaluation rather than watchful waiting at home. More broadly, if vomiting or diarrhoea has continued for more than 24 hours and you can't keep fluids down, contact your GP or call NHS 111. Don't delay because you assume it will pass. If you've been wondering about what constitutes a serious adverse event with Wegovy, dehydration from uncontrolled GI illness falls into the category that needs clinical input rather than self-management.
If a dose was delayed or missed while you've been unwell, there's straightforward guidance on what to do if Wegovy is taken late, always follow your prescriber's advice and the patient information leaflet rather than making dose decisions based on online searches. Our clinical team at nume (sorry, at our pharmacy) is available for aftercare seven days a week if you have questions about your treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.